Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
correlations, characterizing disease progression, and exploring early disease changes. This knowledge is crucial to improve prognosis, patient care guidance and support the development of future gene-based
-
plasma-/bio-/chemo-catalysts under the supervision of Professor Joke Hadermann. The PhD project is part of a broader research effort focused on developing innovative technologies for the sustainable
-
of teaching and research, the FSTM seeks to generate and disseminate knowledge and train new generations of responsible citizens in order to better understand, explain and advance society and environment we
-
to arrange working at both host institutions (UAntwerp and KU Leuven), located ca. 50 km apart with a direct train connection in-between. What we offer We offer a doctoral scholarship for a period of 1 year
-
translational cancer research. Omics based strategies, such as (epi-)genomics and transcriptomics, are opening unprecedented potential for developing novel precision oncology tools for improved diagnosis
-
to perform the following tasks: Contribute to the development of a comprehensive channel model for the C-band direct-to-device (D2D) satellite communications in rural, semiurban and urban scenarios
-
colleagues. Would you like more information about EUTOPIA? Go to eutopia-university.eu , and read more about the role of the VUB in the development of the EUTOPIA alliance. Where to apply Website https
-
. Clinical studies have demonstrated that hereditary neuropathies can also involve muscle pathologies, complicate diagnosis and hamper therapy development. We have developed advanced in vitro cell models
-
set a course for the future – a future that you can help to shape. The EMAT research group at the Faculty of Science (University of Antwerp) is seeking to fill a PhD position on the development
-
that combines structural biology, biochemistry, and cell biology. The lab is particularly focused on biomolecular interactions, characterizing regulatory complexes, and developing novel therapeutic